Dr. Boidin's ongoing research, set to conclude in March 2025, challenges the widely held belief that vaping is significantly less harmful than smoking, indicating that continuous vaping can lead to health issues similar to those faced by smokers.

A groundbreaking study led by Dr. Maxime Boidin at Manchester Metropolitan University suggests that vaping may pose greater health risks than smoking, potentially increasing the risk of dementia, heart disease, and organ failure.

In Britain, approximately 5.1 million people vape, with the highest usage among those aged 16 to 24, raising significant concerns about the long-term health implications of widespread vaping.

The study involved participants aged 18 to 45, who underwent stress tests that revealed both smokers and vapers exhibited impaired artery function, indicating future cardiovascular risks.

Participants expressed shock at the study's findings, with individuals like Adam Petrulevic and Marine, who initially believed vaping was safer than smoking, now reconsidering their habits.

Despite the alarming data, the UK Vaping Industry Association has downplayed the study's conclusions, asserting that vaping poses minimal health risks compared to smoking.

In response to these health concerns, the UK government has proposed banning disposable vapes and implementing stricter regulations, while Dr. Boidin advocates for all vaping products to be available only by prescription.

Dr. Boidin highlights that unlike smoking, which typically requires frequent breaks, vaping allows for continuous consumption, making it easier for users to overindulge.

Findings from the study showed that the chemicals and metals in vaping products cause inflammation and oxidative stress, leading to artery damage and potential cognitive dysfunction.